The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome

被引:39
作者
Lechner, BL [1 ]
Bockenhauer, D [1 ]
Iragorri, S [1 ]
Kennedy, TL [1 ]
Siegel, NJ [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, New Haven, CT 06510 USA
关键词
nephrosis; hyperlipidemia; cholesterol-lowering agents; corticosteroids; myocardial infarction;
D O I
10.1007/s00467-004-1460-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
While increased risk of cardiovascular disease (CVD) in patients with hyperlipidemia, chronic kidney disease (CKD), or end-stage renal disease (ESRD) is well documented, transient hyperlipidemia or intermittent renal disease as a consequence of relapsing nephrotic syndrome (NS) has not been studied. To investigate this enigma, 62 patients, between 25 and 53 years of age, who had steroid-responsive/dependent NS during childhood, were identified from the records of the Division of Pediatric Nephrology at Yale School of Medicine. Forty patients were located and contacted to ascertain symptoms or occurrences of CVD via a telephone interview. At the time of follow-up, 23-46 years after cessation of NS, none of these patients had ESRD or CKD. Three patients had experienced a myocardial infarction (MI): a 32-year-old male with a family history of CVD; a 41-year-old male with a history of heavy smoking, hypertension, diabetes mellitus, and elevated cholesterol; a 31-year-old male after a cocaine overdose. The occurrence of events (8%) and mortality from CVD (none) in this cohort of patients is comparable to patients of a similar age in the general population and is lower than that of patients of the same age who are on dialysis. The data suggest that relapsing NS during childhood does not place patients at increased risk for CVD mortality or morbidity compared with the general population. Consequently, it would appear that factors related to persistent proteinuria or renal insufficiency, rather than transient proteinuria and renal disease, contribute to the CVD documented in patients with CKD or ESRD.
引用
收藏
页码:744 / 748
页数:5
相关论文
共 18 条
[11]  
*NIH, 2002, ALT END STAG REN DIS
[12]   Should hyperlipidemia in children with the nephrotic syndrome be treated? [J].
Querfeld, U .
PEDIATRIC NEPHROLOGY, 1999, 13 (01) :77-84
[13]  
Roth Karl S, 2002, Pediatr Rev, V23, P237, DOI 10.1542/pir.23-7-237
[14]   Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management [J].
Saland, JM ;
Ginsberg, H ;
Fisher, EA .
CURRENT OPINION IN PEDIATRICS, 2002, 14 (02) :197-204
[15]   Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapy [J].
Sanjad, SA ;
AlAbbad, A ;
AlShorafa, S .
JOURNAL OF PEDIATRICS, 1997, 130 (03) :470-474
[16]   Epidemiology of cardiac disease in dialysis patients [J].
Sarnak, MJ ;
Levey, AS .
SEMINARS IN DIALYSIS, 1999, 12 (02) :69-76
[17]  
Tarshish P, 1997, J AM SOC NEPHROL, V8, P769
[18]  
WHITE RHR, 1970, LANCET, V1, P1353